Lithera, Inc.
Records under this name other than patents Lithera, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Lithera, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,707,192 | Lipolytic methods Formerly held Lapsed on the fee record Ended Jul 18, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2021 | From the USPTO record |
| US 8,420,625 | Lipolytic methods for regional adiposity Formerly held Lapsed on the fee record Ended Apr 16, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2021 | From the USPTO record |
| US 8,404,750 | Methods for administration and formulations for the treatment of regional adipose tissue Formerly held Lapsed on the fee record Ended Mar 26, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 26, 2021 | From the USPTO record |
| US 9,597,531 | Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging Formerly held Lapsed on the fee record Ended Mar 21, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 21, 2021 | From the USPTO record |
| US 9,370,498 | Methods of using lipolytic formulations for regional adipose tissue treatment Formerly held Lapsed on the fee record Ended Jun 21, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 21, 2020 | From the USPTO record |
| US 9,198,885 | Lipolytic methods for regional adiposity comprising salmeterol or formoterol Formerly held Lapsed on the fee record Ended Dec 1, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 1, 2019 | From the USPTO record |
| US 9,132,084 | Methods for administration and formulations for the treatment of regional adipose tissue Formerly held Lapsed on the fee record Ended Sep 15, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2019 | From the USPTO record |
| US 7,829,554 | Sustained release enhanced lipolytic formulation for regional adipose tissue treatment Formerly held Lapsed on the fee record Ended Nov 9, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 9, 2018 | From the USPTO record |